baber/WOPTO huggingface dataset:
Patent MX-2019000883-A (MX)
Title: Method and system for detecting seismic events.
Inventor: Pascal VIBERT-CHARBONNEL
IPC: G01V1/24
Filed: 2017-07-25
Abstract: The invention relates to a method for detecting seismic events, which comprises acquiring (110) a digital signal x characteristic of a signal measured by at least one seismic sensor; and calculating (130) a time-frequency distribution of at least one slice of a given duration of said signal, in a given frequency band. For each frequency of said frequency band, the calculated time-frequency distribution is normalised. The method also comprises calculating (150) the moving average of the normalised time-frequency distribution ZD, in said frequency band and in a time window, denoted L, centred on the time n; and detecting (160) a seismic event when the average passes above a predefined threshold value. The invention also relates to a corresponding detecting system.
Patent MX-2019002850-A (MX)
Title: Novel aminobisphosphonate antiwear additives.
Inventor: JOHN MARSHALL BAKER
IPC: C07F9/40
Filed: 2017-09-18
Abstract: The present invention relates to novel aminobisphosphonate compounds useful as antiwear and/or friction modifier additive components, lubricant additive compositions and lubricant compositions each comprising such compounds, and methods for making and using the same.
Patent MX-2019004090-A (MX)
Title: Controllable high flow concrete.
Inventor: LAWRENCE L KUO
IPC: C04B28/02
Filed: 2017-10-11
Abstract: The present invention relates to very high workable yet controllable concrete mix design, admixture composition, and process for placing concrete. The mix design relates to particular aggregate/cement ratios and types which are characteristic of ready mix concrete (RMC), which provide high fluidity reminiscent of self-consolidating concrete (SCC), and which provides advantages over both RMC and SCC in terms of ease and speed in placement and finishability at the construction site placement zone, regardless of whether into a horizontal formwork (e.g., for slabs, floors) or into vertical formwork (e.g., for blocks, walls, columns, etc.), without loss of control and without generating high risks of segregation even when small amounts of water are added at the size to facilitate finishing of the concrete surface. An inventive admixture combination which enables this unique design involves two different polycarboxylate comb polymers in combination with two specific viscosity modifying agents, and this combination provides highly workable concrete to be placed in a controlled, efficient manner.
Patent MX-2019011020-A (MX)
Title: Vending system.
Inventor: ALFONSO JAVIER BARRAGÁN RODRÍGUEZ
IPC: G06Q20/18
Filed: 2016-04-04
Abstract: An embodiment includes a system comprising a first vending machine (VM), the first VM comprising: an exterior chassis having a top, bottom, backside, front side, and first and second sides that couple the front side to the backside; a wireless short range communications node included in the chassis; and an actuator coupled to a compartment included in the chassis; wherein (a) the actuator provides a vended good to an aperture in the front side upon actuation, and (b) each of the front side and first and second sides includes no physically manipulatable consumer interface with which the consumer can control the first VM via direct physical manipulation of the first VM. Other embodiments are described herein.
Patent MX-2019011837-A (MX)
Title: Topical localized isoxazoline formulation comprising glycofurol.
Inventor: HEIKE WILLIAMS
IPC: A61K47/18
Filed: 2013-06-26
Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising glycofurol and an improved method for controlling, and preventing parasite infestation in animals.
Patent MX-2019014547-A (MX)
Title: Orthotic device for recovering movement and rehabilitation of the upper members.
Inventor: FLORES LUNA ROSA ITZEL
IPC: A61F5/00
Filed: 2019-12-04
Abstract: The present invention relates to a glove-type orthotic device for the recovery of movement and rehabilitation of the upper limbs. It comprises initial support for the user's forearm, restoring and compensating the damage caused by injuries, allowing aligning and supporting the upper limbs and the wrist. Also, it includes sling-type secondary support for positioning the arm, a tensioning element with flexible and elastic characteristics to join said supports. Further, a rigid component locates inside the main body for the wrist.
Patent MX-2019015793-A (MX)
Title: Auto-injector with anti-roll features.
Inventor: ALEXEI GORALTCHOUK
IPC: A61M5/31
Filed: 2018-06-29
Abstract: The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, wherein the cap may include a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross- sectional dimension larger than the first cross-sectional dimension. The cap may further include a curved sidewall extending radially outward from the first end to the second end, and the curved sidewall may include a protrusion.
Patent MX-2020000166-A (MX)
Title: Energy cured heat activated ink jet adhesives for foiling applications.
Inventor: LIU XIANG
IPC: C08J7/04
Filed: 2018-06-26
Abstract: Adhesive compositions that can be applied to substrates using inkjet printheads and cured to a hardened, tack-free state and readily rendered tacky on application of heat and pressure to accurately transfer foil to the substrates including one or more free-radical curing monomers, an oligomer/resin composition component including one or more oligomers and one or more inert thermoplastic resins that are soluble in the monomers, and, where required, one or more free radical photoinitiators.
Patent MX-2020001482-A (MX)
Title: Method for etching a phosphate source using acid.
Inventor: WAVREILLE ALEXANDRE
IPC: C01B25/22
Filed: 2018-08-10
Abstract: A method for etching a phosphate source with or without calcium using sulphuric acid for a predetermined period of time of between 20 and 180 minutes under conditions whereby the sulphate molar ratio from the sulphuric acid as well as optionally the phosphate source with calcium present in the phosphate source is between 0.6 and 0.8, and the content of P<sub>2</sub>O<sub>5</sub> in the etching tank is less than 6%.
Patent MX-2020003883-A (MX)
Inventor: LANGE SABINE
IPC: A61Q19/00
Filed: 2017-10-10
Abstract: Se sugieren composiciones cosméticas con estabilidad mejorada, que comprende al menos un compuesto de fórmula (I) o sus sales como aditivos.
Patent MX-2020005305-A (MX)
Title: Pouch-type orally dissolving films with high active ingredient concentration.
Inventor: SCHMITZ CHRISTOPH
IPC: A61K9/00
Filed: 2018-11-21
Abstract: The invention relates to a dosage form for an active ingredient, to be dissolved in the oral cavity, comprising a first film layer and a second film layer that is arranged over the first film layer, wherein the composition of the first film layer can be identical to that of the second and comprises a water-soluble polymer, said first and the second film layers being interconnected by their overlapping edges so as to form at least one cavity and this cavity being filled with an active ingredient. In this configuration, the dosage form takes the form of a pouch made from two water-soluble film layers so that said film layers dissolve when the pouch is put in the mouth, and an active ingredient contained in said pouch can be released. This pouch configuration makes it possible to have a higher content of the active ingredient than comparable OTF films while avoiding thermal stress on said active ingredient during production of the dosage form. The advantageous properties of known thin-film dosage forms are substantially retained. The invention also relates to a method for producing the dosage form.
Patent MX-2020006661-A (MX)
Title: Infusion set for measuring vital signals of a patient comprising a compliance element and a reflective element.
Inventor: ROVATTI PAOLO
IPC: A61M5/172
Filed: 2018-12-21
Abstract: There is provided an IV infusion set comprising a patient access configured to connect to a vascular system of a patient, a source of medical fluid, an infusion line having one first end configured to connect to the source of medical fluid and one opposite second end configured to deliver the medical fluid towards the patient access, an infusion apparatus arranged on the infusion line, a sensor configured to emit a pressure signal indicative of a pressure of a medical fluid in the infusion line, and a control unit configured to receive the pressure signal and to determine a patient signal indicative of a vital signal of the patient based on the pressure signal. The IV infusion set further comprises a compliance element configured to attenuate pressure variations of medical fluid the infusion line, and a resistance element configured to reflect pressure waves moving along the infusion line. The sensor is arranged on the infusion line at a position downstream from the resistance element with respect to a direction of fluid flow along the infusion line from the medical fluid source towards the patient access. The infusion line may include a main infusion line and/or one or more auxiliary infusion lines connected to a main infusion line.
Patent MX-2020006723-A (MX)
Title: Terminal device, method, and integrated circuit.
Inventor: YAMADA SHOHEI
IPC: H04W72/04
Filed: 2018-12-27
Abstract: A terminal device for communicating with one or a plurality of base station devices, wherein the terminal device is provided with: a reception unit for receiving an RRC resetting message that includes a DRB setting from the base station devices, the DRB setting including a DRB identifier and an EPS bearer identifier; and a processing unit for associating an established DRB and the EPS identifier when the DRB setting is not part of the current setting of the terminal device and the DRB has been set to the EPS bearer identifier.
Patent MX-2020007040-A (MX)
Title: Compositions comprising co-selected microbiota and methods for use thereof.
Inventor: ALLEN-VERCOE EMMA
IPC: A61K35/74
Filed: 2019-01-04
Abstract: Anhydrous compositions comprising a co-selected microbiota and methods for using same to treat disorders associated with dysbiosis (an imbalance of the microbial community inhabiting a subject or inhabiting a particular tissue in a subject) are described herein. In particular, anhydrous compositions comprising a co-selected microbiota and methods for treating gastrointestinal disorders associated with dysbiosis are envisioned. The use of such anhydrous compositions comprising a co-selected microbiota for treating disorders associated with dysbiosis (e.g., gastrointestinal disorders associated with dysbiosis) and the use of such anhydrous compositions comprising a co-selected microbiota in the preparation of a medicament for treating disorders associated with dysbiosis (e.g., gastrointestinal disorders associated with dysbiosis) are also embodied herein.
Patent MX-2020007899-A (MX)
Title: Compounds.
Inventor: WALKER EDWARD
IPC: C07D413/12
Filed: 2019-01-25
Abstract: Compounds of general formula (I): wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup>, R<sup>5a</sup>, R<sup>5b</sup> X<sup>1</sup>, X<sup>2</sup>, Z and Y are as defined herein are positive modulators of the calcium-activated chloride channel (CaCC), TMEM16A. The compounds are useful for treating diseases and conditions affected by modulation of TMEM16A, particularly respiratory diseases and conditions.
Patent MX-2020009183-A (MX)
Title: Crystalline forms of an sgc stimulator.
Inventor: NTI-ADDAE KWAME W
IPC: A61K31/4985
Filed: 2019-03-07
Abstract: The present disclosure relates to crystalline forms of 8-(2-fluorobenzyl)-6-(3-(trifluoromethyl)-1H-1,2,4-triazol-5-yl )imidazo[l,2-a]pyrazine, which are useful as a stimulator of soluble guanylate cyclase (sGC). The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline forms and methods of using said compositions in the treatment of various disorders.
Patent MX-2020010900-A (MX)
Title: Inhibitors of lysine specific demethylase-1.
Inventor: NIE ZHE
IPC: C07D417/04
Filed: 2015-06-29
Abstract: The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Patent MX-2021002888-A (MX)
Title: Pharmaceutical combinations for treating tumor comprising anti-cd19 antibody and natural killer cell.
Inventor: BOXHAMMER RAINER
IPC: C07K16/28
Filed: 2019-09-05
Abstract: Provided is a pharmaceutical combination comprising an antibody specific for CD19 and a natural killer cell, and a treatment method using the same. Such a pharmaceutical combination is capable of exhibiting synergistic therapeutic effects on a malignant tumor of B-cell origin such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and/or acute lymphoblastic leukemia.
Patent MX-2021007885-A (MX)
Title: Methods and compositions for treating skin and hair disorders.
Inventor: MOSELEY TIMOTHY ALEXANDER
IPC: C12N5/077
Filed: 2019-12-26
Abstract: Disclosed are treatment mesenchymal stem cell growth factor compositions and methods of their use to treat skin disorders, hair greying, baldness, and erectile dysfunction as well as their use in skin color/ethnic specific cosmetic and skin treatments. In some aspects, the treatment target SNPs specific to the hair color, skin color, skin type, hair type, race, ethnicity, and/or response to testosterone.
Patent MX-2021012596-A (MX)
Title: Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance.
Inventor: VINOCUR BASIA JUDITH
IPC: A01H5/00
Filed: 2014-05-26
Abstract: Provided are methods of increasing nitrogen use efficiency, yield, biomass, growth rate, vigor, oil content, fiber yield, fiber quality and/or abiotic stress tolerance of a plant by expressing within the plant an exogenous polynucleotide comprising a nucleic acid sequence at least 80 % identical to SEQ ID NO: 387, 1-386, 388-469, 763-3704 and 3705; or an exogenous polynucleotide encoding a polypeptide at least 80 % identical to SEQ ID NO: 602, 470-601, 603-762, 3706-5858, 5860-5910, 5912, 5914- 5923, 5925-6046 or 6047. Also provided is an isolated polynucleotide comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 387, 1-386, 388-469, 763-3704 and 3705, which can be used to increase the nitrogen use efficiency, yield, biomass, growth rate, vigor, oil content, fiber yield, fiber quality and/or abiotic stress tolerance of a plant.
Patent MX-2021013123-A (MX)
Title: Use of co-crystals of tramadol and celecoxib for treating pain while reducing the abuse liability of tramadol.
Inventor: ENCINA-GARCÍA GREGORIO-JOSÉ
IPC: A61K31/415
Filed: 2020-05-13
Abstract: The present invention relates to the use of co-crystals of tramadol and celecoxib for the treatment of pain, preventing the risk of an addiction to tramadol, for the treatment of pain while reducing the abuse liability of tramadol, for the treatment of pain also reducing an incidence of addiction to tramadol, for the treatment of pain preventing an addiction to tramadol, for the treatment of pain in a patient with an addiction to tramadol or the risk of it, for the treatment of pain and inhibiting, delaying, reducing or reversing an addiction to tramadol or for treatment of pain and reducing an incidence of addiction to tramadol.
Patent MX-2021014291-A (MX)
Title: Wireless detonator assembly.
Inventor: MULLER ELMAR LENNOX
IPC: F42D1/05
Filed: 2021-02-02
Abstract: A wireless detonator assembly which includes a detonator, a receiver, a printed circuit board with a stored key which is hardwired onto the board during manufacture of the detonator assembly and control logic which allows the detonator to be fired only if the control logic extracts from a signal, received by the receiver, a reference key which is identical to the stored key.
Patent MX-2021015879-A (MX)
Title: Constrained peptides.
Inventor: GADEK THOMAS R
IPC: C07K14/475
Filed: 2020-06-17
Abstract: This application generally relates to constrained salts of peptides, constrained forms of peptides, and compositions, kits, methods of using, or uses of the same.
Patent MX-2022004577-A (MX)
Title: Immunomodulatory il-2 agents in combination with immune checkpoint inhibitors.
Inventor: LOSEY HEATHER C
IPC: A61K38/20
Filed: 2020-10-16
Abstract: The invention provides compositions and methods of treating cancer in a patient with a combination therapy comprising a fusion protein of SEQ ID NO: 1 in combination with an immune checkpoint inhibitor. Preferably the patient has failed to achieve complete or partial response with prior or ongoing treatment with an immune checkpoint inhibitor.
Patent MX-2022006882-A (MX)
Title: Formulations of anti-cd38 antibodies for subcutaneous administration.
Inventor: CHARI RAVI
IPC: C07K16/28
Filed: 2020-12-04
Abstract: Provided are formulations of anti-CD38 antibodies suitable for subcutaneous administration to a subject in need thereof. The formulations include a high concentration of antibody, a viscosity lowering agent, a stabilizing agent, a buffering agent and a surfactant. In certain embodiments, the viscosity of the solution is at most 25 mPaÂ·s, and the pH of the solution is 5.9 to 7.0. In certain embodiments, the anti-CD38 antibody is isatuximab. The formulations will find use in treating CD38<sup>+</sup> hematological malignancies, including multiple myeloma, as well as autoimmune and inflammatory diseases, in humans.
Patent MX-2022007759-A (MX)
Title: Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndrome.
Inventor: SUN HAIYING
IPC: C07K16/28
Filed: 2020-12-03
Abstract: Combination therapies comprising TIM-3 inhibitors and TGF-Î² inhibitors are disclosed. The combinations can be used to treat or prevent cancerous conditions and disorders, including myelofibrosis or myelodysplastic syndrome.
Patent MX-2022008944-A (MX)
Title: Audio information transmission system, method, device, corresponding two-wheeled vehicle, and helmet.
Inventor: LIU KE
IPC: G10L19/008
Filed: 2021-01-10
Abstract: Disclosed are an audio information transmission system, a method, a device, a corresponding two-wheeled vehicle, and a helmet. The system comprises a media control device and an audio switching device connected to the media control device. The audio switching device is connected to a mobile terminal and a helmet, and is used to receive first audio information sent by the mobile terminal and send the information to the media control device. The media control device is used to receive the first audio information and second audio information generated by a two-wheeled vehicle, and perform mixing to produce mixed audio information. The audio switching device sends the mixed audio information to the helmet. The present invention performs processing and mixing on audio information transmitted by the mobile terminal and audio information of navigation, alarms, and the like transmitted by the two-wheeled vehicle, and sends mixed audio information to the helmet, such that a user is capable of acquiring audio information sent by a user terminal and information of navigation and the like sent by an electric vehicle without switching between audio information transmitted by the mobile terminal and the electric vehicle, thereby improving riding safety for users, and improving user experience.
Patent MX-2022009446-A (MX)
Title: Compositions for improved nrf2 activation and methods of their use.
Inventor: HYBERTSON BROOKS MICHAEL
IPC: A61P39/06
Filed: 2018-03-02
Abstract: Disclosed here are compositions and methods for preventing or treating certain health conditions associated with inflammation or oxidative stress. These compositions are prepared from ingredients containing phytochemicals that activate the Nrf2 pathways. Synergistic effects of the different phytochemicals are also disclosed.
Patent MX-2022009532-A (MX)
Title: Electrodepositable coating composition having improved crater control.
Inventor: WILSON CRAIG A
IPC: C09D5/44
Filed: 2021-02-26
Abstract: The present invention is directed towards an electrodepositable coating composition comprising a polyfarnesene polymer and an ionic salt group-containing film-forming polymer. Also disclosed are methods of coating a substrate using the electrodepositable coating composition, coatings derived from the electrodepositable coating composition, and substrates coated with the coatings derived from the electrodepositable coating composition.
Patent MX-2022012456-A (MX)
Title: Cell lysis systems and methods.
Inventor: LAHOUD IMAD
IPC: A24B15/167
Filed: 2021-04-01
Abstract: A cell lysis system (1) comprises a driver apparatus (2) and a cell lysis device (3) which are releasably attachable to one another. The cell lysis device (3) comprises an ultrasonic transducer (12) and a sonication chamber (11). The driver apparatus (2) drives the ultrasonic transducer (12) to output ultrasonic waves to lyse cells in a sample container (22) which is carried by the cell lysis device (3).
Patent MX-2022013964-A (MX)
Title: Non-lysosomal glucosylceramidase inhibitors and uses thereof.
Inventor: MCEACHERN ERNEST J
IPC: A61P25/00
Filed: 2021-05-06
Abstract: The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
Patent MX-2022014219-A (MX)
Title: Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (mcl-1) protein.
Inventor: ZHUO JINCONG
IPC: A61P35/00
Filed: 2021-05-13
Abstract: The disclosure is directed to crystalline forms of the compound of Formula I: Formula (I), and pharmaceutically acceptable salts thereof. Pharmaceutical compositions comprising compounds of Formula I as well as methods of their use and preparation, are also described.